Atlas Trials

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Clinical trial NCT07268339 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07268339
Sponsor
The Christie NHS Foundation Trust
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
High-Risk Non-Muscle Invasive Bladder Cancer
Start date
2025-12-01
Primary completion
2031-12-01
Enrollment
328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.